(Q52166464)

English

SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor.

scientific article published in July 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

Marc Parmentier

3

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

author name string

El Yacoubi M

1

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

Ledent C

2

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

Costentin J

4

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

Vaugeois J

5

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

401

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

1

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

63-77

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Mechanism and pressor relevance of the short-term cardiovascular and renin excitatory actions of the selective A2A-adenosine receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Signaling via A2A adenosine receptor in four PC12 cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Role of adenosine A2a receptors in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

NECA-induced hypomotility in mice: evidence for a predominantly central site of action

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Behavioural effects of selective A2 adenosine receptor antagonists, CGS 21197 and CGS 22706, in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Dual signalling by the adenosine A2a receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

A role for central A3-adenosine receptors. Mediation of behavioral depressant effects

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Adenosinergic modulation of the EEG and locomotor effects of the A2 agonist, CGS 21680.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine), a potent and selective adenosine A2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Behavioral characteristics of centrally administered adenosine analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Adenosine in sleep and wakefulness

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Adenosine A2 receptor-mediated excitatory actions on the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Adenosine receptors and behavioral actions of methylxanthines

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Caffeine mimics the effect of a dopamine D2/3 receptor agonist on the expression of immediate early genes in globus pallidus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900399-X

7 January 2021

Identifiers

10.1016/S0014-2999(00)00399-X

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10915839

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52166464&oldid=1373005889"